search
Back to results

Testing the Effect of Multiple Weight Management Modalities for Chronic Disease Risk Reduction in a Clinical Setting (LIHT)

Primary Purpose

Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Low-Carbohydrate Diet
Intermittent Energy Restriction
Hunger Training
Sponsored by
University of Arizona
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring Weight Loss, Diet Modification, Body Weight, Body Weight Changes, Ketogenic diet, Diet, Carbohydrate-Restricted, Fasting, Intermittent Fasting, Hunger training

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Overweight/obese as indicated by BMI >27
  • Age ≥ 18
  • HbA1C <8.0
  • Fluent in English

Exclusion Criteria:

  • Cognitive state that precludes informed consent or adherence to study protocols
  • Pregnant, breast-feeding, or planning to become pregnant within 6 months
  • A1C ≥ 8.0
  • Taking an anti-obesity medication
  • Insulin-dependence
  • prior metabolic surgery
  • current laparoscopic adjustable gastric band ("lap band") use
  • Experience of substantial weight changes (±5 kg or ±10 lbs) in the past 3 months

Sites / Locations

  • University of Arizona

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

Low-Carbohydrate Diet

Intermittent Energy Restriction

Hunger Training

Arm Description

Participants will be instructed to consume less than 30 grams of carbohydrates per day.

Participants choose 2 non-consecutive days per week in which they will consume 500-650 calories.

Participants monitor their hunger symptoms and blood glucose, and eat only when blood glucose is below a certain threshold level.

Outcomes

Primary Outcome Measures

Rate of Recruitment
Feasibility of recruiting participants into a randomized dietary intervention in a clinic setting as measured by the total number of individuals who are screened as eligible and enrolled into the study
Rate of Retention
Feasibility of retaining participants in a randomized dietary intervention in a clinic setting as measured by the number of participants completing all study visits
Adherence to the Intervention
Feasibility of maintaining participant adherence in a randomized dietary intervention in a clinic setting will be measured by attendance at scheduled clinic visits
Change in Weight
Participant weight will be measured
Change in BMI
Participant BMI will be measured
Change in HbA1c
Participant HbA1c will be measured
Change in Fasting Glucose
Participant fasting glucose will be measured
Change in Fasting Insulin
Participant fasting insulin will be measured
Change in Total Cholesterol
Participant total cholesterol will be measured
Change in Triglycerides
Participant triglycerides will be measured
Change in High Density Lipoprotein (HDL)
Participant HDL will be measured
Change in Low Density Lipoprotein (LDL)
Participant LDL will be measured
Change in C-Reactive Protein (CRP)
Participant CRP will be measured
Change in Insulin-like Growth Factor 1 (IGF-1)
Participant IGF-1 will be measured
Change in Insulin-like Growth Factor 2 (IGF-2)
Participant IGF-2 will be measured
Change in Insulin-like Growth Factor Binding Protein 3 (IGFBP-3)
Participant IGFBP-3 will be measured
Change in Leptin
Participant leptin will be measured
Change in Adiponectin
Participant adiponectin will be measured
Participant Satisfaction
Participants will complete a questionnaire at the end of the study to assess the acceptability of and satisfaction with the weight loss diet intervention they received. We will assess overall satisfaction, enjoyment, likeliness to recommend, and ease of following the diet. Aggregated scores will be compared across weight loss modality.

Secondary Outcome Measures

Full Information

First Posted
June 24, 2019
Last Updated
December 16, 2021
Sponsor
University of Arizona
search

1. Study Identification

Unique Protocol Identification Number
NCT03998878
Brief Title
Testing the Effect of Multiple Weight Management Modalities for Chronic Disease Risk Reduction in a Clinical Setting
Acronym
LIHT
Official Title
Testing the Effect of Multiple Weight Management Modalities for Chronic Disease Risk Reduction in a Clinical Setting (LIHT)
Study Type
Interventional

2. Study Status

Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
August 8, 2019 (Actual)
Primary Completion Date
December 16, 2021 (Actual)
Study Completion Date
December 16, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Arizona

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This project will test 3 methods of dietary changes in a weight loss clinic. Participants will be randomized to one of 3 arms: low-carbohydrate diet, intermittent energy restriction, or Hunger Training. A maximum of 30 participants will be assigned to each arm. The goal of the proposed study is to determine the feasibility, early efficacy, and patient satisfaction of each weight loss modality in a population of patients seeking care at a weight loss clinic.
Detailed Description
Adult obesity, a common condition in the United States, is a well-established risk factor for the development of chronic diseases, including diabetes, heart disease, hypertension, and many types of cancer. However, research has not determined what type of diet is best for reducing weight and achieving optimal health outcomes. In this randomized trial, participants seeking care at a weight loss clinic will be assigned to one of three diets: low-carbohydrate, intermittent energy restriction, or Hunger Training. On the low-carbohydrate diet, participants will be instructed to consume less than 30 grams of carbohydrates per day. The intermittent energy restriction protocol will require participants to choose 2 non-consecutive days per week in which they will consume 500-650 calories. Hunger Training is a relatively new approach that involves teaching people to monitor their hunger symptoms and blood glucose, and to eat only when blood glucose is below a certain level. To our knowledge, these weight loss modalities have not been compared in a single, clinical study. The goal of the proposed study is to determine the feasibility, early efficacy, and patient satisfaction of each weight loss modality in a population of patients seeking care at a weight loss clinic. The goal will be achieved though the successful completion of the following aims: Aim 1: To determine the feasibility of recruiting, retaining and maintaining the adherence participants in a randomized clinical trial testing 3 weight loss modalities. Aim 2: To examine and compare the effect of 3 weight loss modalities on changes in anthropometric measures and metabolic and cancer-related health markers. Aim 3: To evaluate and compare patients' perceived satisfaction with each weight loss modality.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Weight Loss, Diet Modification, Body Weight, Body Weight Changes, Ketogenic diet, Diet, Carbohydrate-Restricted, Fasting, Intermittent Fasting, Hunger training

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
9 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Low-Carbohydrate Diet
Arm Type
Experimental
Arm Description
Participants will be instructed to consume less than 30 grams of carbohydrates per day.
Arm Title
Intermittent Energy Restriction
Arm Type
Experimental
Arm Description
Participants choose 2 non-consecutive days per week in which they will consume 500-650 calories.
Arm Title
Hunger Training
Arm Type
Experimental
Arm Description
Participants monitor their hunger symptoms and blood glucose, and eat only when blood glucose is below a certain threshold level.
Intervention Type
Behavioral
Intervention Name(s)
Low-Carbohydrate Diet
Intervention Description
Participants will be instructed to follow a low-carbohydrate diet.
Intervention Type
Behavioral
Intervention Name(s)
Intermittent Energy Restriction
Intervention Description
Participants will be instructed to follow intermittent energy restriction.
Intervention Type
Behavioral
Intervention Name(s)
Hunger Training
Intervention Description
Participants will be instructed to follow Hunger Training.
Primary Outcome Measure Information:
Title
Rate of Recruitment
Description
Feasibility of recruiting participants into a randomized dietary intervention in a clinic setting as measured by the total number of individuals who are screened as eligible and enrolled into the study
Time Frame
1 year
Title
Rate of Retention
Description
Feasibility of retaining participants in a randomized dietary intervention in a clinic setting as measured by the number of participants completing all study visits
Time Frame
1 year
Title
Adherence to the Intervention
Description
Feasibility of maintaining participant adherence in a randomized dietary intervention in a clinic setting will be measured by attendance at scheduled clinic visits
Time Frame
1 year
Title
Change in Weight
Description
Participant weight will be measured
Time Frame
baseline to 3 months
Title
Change in BMI
Description
Participant BMI will be measured
Time Frame
baseline to 3 months
Title
Change in HbA1c
Description
Participant HbA1c will be measured
Time Frame
baseline to 3 months
Title
Change in Fasting Glucose
Description
Participant fasting glucose will be measured
Time Frame
baseline to 3 months
Title
Change in Fasting Insulin
Description
Participant fasting insulin will be measured
Time Frame
baseline to 3 months
Title
Change in Total Cholesterol
Description
Participant total cholesterol will be measured
Time Frame
baseline to 3 months
Title
Change in Triglycerides
Description
Participant triglycerides will be measured
Time Frame
baseline to 3 months
Title
Change in High Density Lipoprotein (HDL)
Description
Participant HDL will be measured
Time Frame
baseline to 3 months
Title
Change in Low Density Lipoprotein (LDL)
Description
Participant LDL will be measured
Time Frame
baseline to 3 months
Title
Change in C-Reactive Protein (CRP)
Description
Participant CRP will be measured
Time Frame
baseline to 3 months
Title
Change in Insulin-like Growth Factor 1 (IGF-1)
Description
Participant IGF-1 will be measured
Time Frame
baseline to 3 months
Title
Change in Insulin-like Growth Factor 2 (IGF-2)
Description
Participant IGF-2 will be measured
Time Frame
baseline to 3 months
Title
Change in Insulin-like Growth Factor Binding Protein 3 (IGFBP-3)
Description
Participant IGFBP-3 will be measured
Time Frame
baseline to 3 months
Title
Change in Leptin
Description
Participant leptin will be measured
Time Frame
baseline to 3 months
Title
Change in Adiponectin
Description
Participant adiponectin will be measured
Time Frame
baseline to 3 months
Title
Participant Satisfaction
Description
Participants will complete a questionnaire at the end of the study to assess the acceptability of and satisfaction with the weight loss diet intervention they received. We will assess overall satisfaction, enjoyment, likeliness to recommend, and ease of following the diet. Aggregated scores will be compared across weight loss modality.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Overweight/obese as indicated by BMI >27 Age ≥ 18 HbA1C <8.0 Fluent in English Exclusion Criteria: Cognitive state that precludes informed consent or adherence to study protocols Pregnant, breast-feeding, or planning to become pregnant within 6 months A1C ≥ 8.0 Taking an anti-obesity medication Insulin-dependence prior metabolic surgery current laparoscopic adjustable gastric band ("lap band") use Experience of substantial weight changes (±5 kg or ±10 lbs) in the past 3 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amit Algotar, MD, PhD, MPH
Organizational Affiliation
University of Arizona, Banner University Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Susan M Schembre, PhD, RD
Organizational Affiliation
University of Arizona
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Arizona
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85714
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Testing the Effect of Multiple Weight Management Modalities for Chronic Disease Risk Reduction in a Clinical Setting

We'll reach out to this number within 24 hrs